Factors associated with the use of sacubitril valsartan in patients with heart failure and reduced ejection fraction.

被引:0
作者
Jorge Thierer, J. [1 ]
Ritondale, N. [2 ]
Palacio, M. S. [3 ]
Lobo Marquez, L. [4 ]
Aguilar, E. [5 ]
Soricetti, J. [6 ]
Ratto, R. [7 ]
Fernandez, D. [8 ]
Sanz, G. [8 ]
Echazarreta, D. [9 ]
Mazo, G. [10 ]
Bauk, L. [11 ]
Martin Napoli, M. [12 ]
Pereiro Gonzalez, S. M. [13 ]
Marino, J. [1 ]
机构
[1] CEMIC, Buenos Aires, DF, Argentina
[2] Delta Sanat, Rosario, Argentina
[3] Clin Bazterr, Buenos Aires, DF, Argentina
[4] Inst Cardiol, San Miguel De Tucuman, Tucuman, Argentina
[5] Ctr Cardiovasc Clin Yunes, Santiago Del Estero, Argentina
[6] Hosp Durand, Buenos Aires, DF, Argentina
[7] Favaloro Fdn Univ Hosp, Buenos Aires, DF, Argentina
[8] Argentine Soc Cardiol SAC, Buenos Aires, DF, Argentina
[9] Hosp San Juan Dios, La Plata, Argentina
[10] Fdn Dr Jose Jalil, Catamarca, Argentina
[11] Sanatorio Cudad, Puerto Madryn, Argentina
[12] Austral Univ Hosp, Pilar, Argentina
[13] Hosp Ctr Churruca Visca, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1309
引用
收藏
页码:228 / 229
页数:2
相关论文
共 50 条
[31]   Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction [J].
Mohebi, Reza ;
Liu, Yuxi ;
Felker, G. Michael ;
Prescott, Margaret F. ;
Ward, Jonathan H. ;
Pina, Ileana L. ;
Butler, Javed ;
Solomon, Scott D. ;
Januzzi, James L. .
JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) :1673-1682
[32]   Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction [J].
Passino, Claudio ;
Sciarrone, Paolo ;
Vergaro, Giuseppe ;
Borrelli, Chiara ;
Spiesshoefer, Jens ;
Gentile, Francesco ;
Emdin, Michele ;
Giannoni, Alberto .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 :112-119
[33]   Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction [J].
Kido, Kazuhiko ;
Bianco, Christopher ;
Caccamo, Marco ;
Hashiguchi, Masayuki ;
Choo, Lyn Yuen ;
Sokos, George .
JOURNAL OF PHARMACY PRACTICE, 2024, 37 (03) :708-711
[34]   Left ventricular ejection fraction recovery in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan. [J].
Diez Villanueva, P. ;
De la Cuerda, F. ;
Vicent, L. ;
Esteban-Fernandez, A. ;
Gomez-Bueno, M. ;
De Juan, J. ;
Iniesta, A. M. ;
Ayesta, A. ;
Rojas, A. ;
Bover, R. ;
Iglesias, D. ;
Garcia Aguado, M. ;
Perea Egido, J. A. ;
Salamanca, J. ;
Martinez-Selles, M. .
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 :206-207
[35]   Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction [J].
Stafylas, P. ;
Farmakis, D. ;
Giamouzis, G. ;
Hatzikou, M. ;
Kourlaba, G. ;
Papatsouma, I. ;
Maniadakis, N. .
EUROPEAN HEART JOURNAL, 2016, 37 :730-731
[36]   Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan [J].
Rex C. Liu .
American Journal of Cardiovascular Drugs, 2018, 18 :473-482
[37]   Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF) [J].
Nowak, Bernd ;
Geiss, Ernst ;
Boehm, Michael ;
Weil, Joachim ;
Boer, Jana .
KARDIOLOGIE, 2023, :44-48
[38]   Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction [J].
Abumayyaleh, Mohammad ;
El-Battrawy, Ibrahim ;
Behnes, Michael ;
Borggrefe, Martin ;
Akin, Ibrahim .
FUTURE CARDIOLOGY, 2020, 16 (04) :227-236
[39]   Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction [J].
Bruno, Rosa Maria ;
Taddei, Stefano .
EUROPEAN HEART JOURNAL, 2017, 38 (15) :1144-1146
[40]   Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction [J].
Raschi, Emanuel ;
Diemberger, Igor ;
Sabatino, Mario ;
Poluzzi, Elisabetta ;
De Ponti, Fabrizio ;
Potena, Luciano .
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) :303-320